1 Nov 10

10-Minute Interview: Chee H. Kim, MD

Dr. Chee Kim is an electrophysiologist with Buffalo Medical Group (BMG) and director of the Electrophysiology Laboratory at Erie County Medical Center (ECMC) in Buffalo, New York.

Tell us about your medical background and how you came to work in the field of electrophysiology. What interested you about this field?

I completed my fellowships in cardiology and electrophysiology at the University of Rochester/Strong Memorial Hospital in 1995. I served on the faculty at Strong Memorial Hospital until 1998, choosing to go into private practice at that time. I chose electrophysiology because it demands excellence in both intellectual and technical/interventional skills. The instant gratification of a successful ablation was quite addicting.

Describe your work as an electrophysiologist at the Buffalo Medical Group and as the director of the EP lab at Erie County Medical Center. Do you split your time between any other institutions as well?



Case Report: Pacing With Closed Loop Stimulation

Neurocardiogenic syncope (NCS) in patients who are refractory to conventional measures such as pharmacological treatment and/or implantation of standard pacemakers can be trying to both patient and physician. Quality of life as well as the importance of preventing serious injury as a result of syncopal events are major concerns. In patients with trigger-mediated vasovagal syncope, it is sometimes especially difficult to control symptoms with conventional therapy.



Medical Mission in Iraq: Highlighting the Work of the Preemptive Love Coalition

In this interview we speak with Matt Willingham from the Preemptive Love Coalition (PLC), a medical coalition that helps to provide lifesaving heart surgery for Iraqi children.

How did you get started? Describe Preemptive Love Coalition’s background.



Left Atrial Appendage Occlusion with the Amplatzer Cardiac Plug

In June 2010, Dr. William Nicholson and colleagues at York Hospital became the first hospital in the country to implant a cardiac plug device. Learn more about this technology below.

Atrial fibrillation (AF) is the most common arrhythmia encountered in the general population. The prevalence of AF clearly increases with patient age, occurring in greater than 9% of the United States population over the age of 80.1 In treating patients with AF, the goals are mitigating symptoms and stroke prevention. Regardless of whether the treating physician chooses to adopt a rhythm or rate control strategy, the risk of stroke as a result of AF persists.



Initial Experience with the Carto® 3 Navigation System (See Full Title Below)

Initial Experience with the Carto® 3 Navigation System:
System Provides Enhanced Efficacy and Precision of Electroanatomical Mapping

Electrophysiologists at Gagnon Cardiovascular Institute were the first in the nation to use a new 3-D mapping system, acquiring the system in November 2009. In this article, the authors describe their experience using this advanced imaging technology.



Tour of the New Hybrid, Robotic Operating Room at Methodist: Interview with Dr. Miguel Valderrábano

The Methodist DeBakey Heart & Vascular Center recently opened an innovative hybrid, robotic operating suite, which integrates advanced robotics, imaging and navigation with surgery to offer patients the least invasive and safest surgical and interventional treatments for cardiovascular disease. In this interview we speak with Dr. Valderrábano, chief of the division of cardiac electrophysiology at Methodist, about the types of procedures that will take place in the new hybrid suite.

What prompted the creation of the new hybrid, robotic operating room?



Hybrid Ablation Protocols for Atrial Fibrillation

In this article, the author discusses his clinical experience with hybrid endocardial and epicardial ablation at the Swedish Heart and Vascular Institute.



Subcutaneous ICD Implantation

Electrophysiologists from the Hospital of the University of Pennsylvania were the first in the region to implant a new subcutaneous defibrillator system. The device implantation is part of an ongoing clinical trial; learn more about the system in this feature article.



When Will Health Insurance Companies Start Denying Coverage for Implantable Defibrillators? They’ve Already Started.

Dear Readers,

The Affordable Care Act prohibits health insurance plans from putting “lifetime” dollar limits on covered services. It will also prohibit insurance companies from denying coverage of patients with preexisting medical conditions. These changes have been touted as a victory for patients with chronic diseases. However, it looks like the health insurance companies are one step ahead.

A colleague recently informed me that his patient was denied coverage by her health insurance provider for a defibrillator generator replacement. This seemed impossible. Unfortunately it is true. His patient with congestive heart failure underwent implantation of a defibrillator for primary prevention of sudden death in the late 1990s as part of the SCD-HeFT Trial. Her insurance covered the device implantation, even though it was investigational at the time. A few years after device implantation, she received a lifesaving shock for an episode of syncopal ventricular fibrillation.



Trinity Health System

What is the size of your EP lab facility and number of staff members? What is the mix of credentials at your lab?

Trinity operates one EP lab. There are four staff members assigned as core staff. These staff members also rotate to the cardiac holding area as well as the cardiac catheterization area and peripheral vascular lab. Qualified staff includes registered nurses, surgical scrub technicians and radiology/cardiovascular technicians.

When was the EP lab started at your institution?

Electrophysiology studies started at Trinity in 2002. The lab was upgraded with the addition of two board-certified electrophysiologists, Dr. Maninder Bedi and Dr. Kat Maleki, in 2007 and 2009.

What types of procedures are performed at your facility?



  • « Previous
  •  | Page 1 of 2 | 
  • Next »